Year |
Citation |
Score |
2023 |
Wang Y, Huang J, Ang TFA, Zhu Y, Tao Q, Mez J, Alosco M, Denis GV, Belkina A, Gurnani A, Ross M, Gong B, Han J, Lunetta KL, Stein TD, et al. Circulating Endothelial Progenitor Cells Reduce the Risk of Alzheimer's Disease. Medrxiv : the Preprint Server For Health Sciences. PMID 36711847 DOI: 10.1101/2023.01.16.23284571 |
0.545 |
|
2019 |
Andrieu GP, Shafran JS, Smith CL, Belkina AC, Casey AN, Jafari N, Denis GV. BET Protein Targeting Suppresses the PD-1/PD-L1 Pathway in Triple-Negative Breast Cancer and Elicits Anti-Tumor Immune Response. Cancer Letters. PMID 31473251 DOI: 10.1016/j.canlet.2019.08.013 |
0.564 |
|
2017 |
Alamoud K, Sadykov K, Kartha V, Monti S, Belkina A, Snyder-Cappione J, Pai S, Kukuruzinska M. Abstract 803: Targeting β-catenin/CBP signaling in OSCC Cancer Research. 77: 803-803. DOI: 10.1158/1538-7445.Am2017-803 |
0.305 |
|
2016 |
Andrieu G, Belkina AC, Denis GV. Clinical trials for BET inhibitors run ahead of the science. Drug Discovery Today. Technologies. 19: 45-50. PMID 27769357 DOI: 10.1016/j.ddtec.2016.06.004 |
0.62 |
|
2016 |
Deeney JT, Belkina AC, Shirihai OS, Corkey BE, Denis GV. BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell. Plos One. 11: e0151329. PMID 27008626 DOI: 10.1371/Journal.Pone.0151329 |
0.628 |
|
2014 |
Bragdon B, Burns R, Baker AH, Belkina AC, Morgan EF, Denis GV, Gerstenfeld LC, Schlezinger JJ. Intrinsic Sex-Linked Variations in Osteogenic and Adipogenic Differentiation Potential of Bone Marrow Multipotent Stromal Cells. Journal of Cellular Physiology. PMID 24962433 DOI: 10.1002/Jcp.24705 |
0.537 |
|
2014 |
Belkina AC, Blanton WP, Nikolajczyk BS, Denis GV. The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis. Journal of Leukocyte Biology. 95: 451-60. PMID 24319289 DOI: 10.1189/jlb.1112588 |
0.628 |
|
2013 |
DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova YR, Markham D, Strissel KJ, Watkins AA, Zhu M, Allen J, Bouchard J, Toraldo G, Jasuja R, Obin MS, et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proceedings of the National Academy of Sciences of the United States of America. 110: 5133-8. PMID 23479618 DOI: 10.1073/Pnas.1215840110 |
0.633 |
|
2013 |
Belkina AC, Nikolajczyk BS, Denis GV. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. Journal of Immunology (Baltimore, Md. : 1950). 190: 3670-8. PMID 23420887 DOI: 10.4049/jimmunol.1202838 |
0.612 |
|
2012 |
Banerjee C, Archin N, Michaels D, Belkina AC, Denis GV, Bradner J, Sebastiani P, Margolis DM, Montano M. BET bromodomain inhibition as a novel strategy for reactivation of HIV-1 Journal of Leukocyte Biology. 92: 1147-1154. PMID 22802445 DOI: 10.1189/Jlb.0312165 |
0.595 |
|
2012 |
Belkina AC, Denis GV. BET domain co-regulators in obesity, inflammation and cancer. Nature Reviews. Cancer. 12: 465-77. PMID 22722403 DOI: 10.1038/nrc3256 |
0.607 |
|
2011 |
Ehrlich DJ, McKenna BK, Evans JG, Belkina AC, Denis GV, Sherr DH, Cheung MC. Parallel imaging microfluidic cytometer. Methods in Cell Biology. 102: 49-75. PMID 21704835 DOI: 10.1016/B978-0-12-374912-3.00003-1 |
0.547 |
|
2010 |
Belkina AC, Denis GV. Obesity genes and insulin resistance. Current Opinion in Endocrinology, Diabetes, and Obesity. 17: 472-7. PMID 20585247 DOI: 10.1097/MED.0b013e32833c5c48 |
0.592 |
|
2010 |
Wang F, Liu H, Blanton WP, Belkina A, Lebrasseur NK, Denis GV. Brd2 disruption in mice causes severe obesity without Type 2 diabetes. The Biochemical Journal. 425: 71-83. PMID 19883376 DOI: 10.1042/Bj20090928 |
0.635 |
|
Show low-probability matches. |